The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice L Xu, A Surathu, I Raplee, A Chockalingam, S Stewart, L Walker, L Sacks, ... BMC genomics 21, 1-18, 2020 | 56 | 2020 |
Aligning the aligners: Comparison of rna sequencing data alignment and gene expression quantification tools for clinical breast cancer research ID Raplee, AV Evsikov, C Marín de Evsikova Journal of personalized medicine 9 (2), 18, 2019 | 36 | 2019 |
Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment I Raplee, L Walker, L Xu, A Surathu, A Chockalingam, S Stewart, X Han, ... Antimicrobial resistance & infection control 10, 1-11, 2021 | 27 | 2021 |
The transcriptomic toolbox: resources for interpreting large gene expression data within a precision medicine context for metabolic disease atherosclerosis C Marín de Evsikova, ID Raplee, J Lockhart, G Jaimes, AV Evsikov Journal of Personalized Medicine 9 (2), 21, 2019 | 9 | 2019 |
Indication switching of the FDA-approved anticancer tyrosine kinase inhibitors to treat metabolic diseases. J Sun, L Yang, M Li, Z Wang, A Haynes, Q Wang, I Raplee, J Melchisedek, ... Cancer Research 73 (8_Supplement), 2040-2040, 2013 | 1 | 2013 |
Contribution of Retrotransposons to Breast Cancer Malignancy ID Raplee | | 2019 |
Dynamic changes in transposon expression and epigenetic regulators detected during early breast cancer transition to malignancy ID Raplee, A Evsikov, CM Evsikova Cancer Research 78 (13_Supplement), 2248-2248, 2018 | | 2018 |